From the webinars
Hi,
Both Dr. Scheinberg and Dr. Antin mentioned it in their presentations at the AAMDS regional conference in Boston. I think Scheinberg was recorded talking about at the Arizona conference as well.
They chuckled when they called it the "homeopathic dose." I think it would be worth doing an investigation as to why this occurs.
The NIH is a little strange about how they define "relapse." Actually, they have a very tight definition of "needing more treatment." Maybe that had something to do with it.
I think it was a European study that showed that a long slow taper reduced relapse to 6%.
__________________
Ryan Jay: 38-yo, dx SAA: 7/25/10, ATG: 8/10/10. CR with counts still rising. HGB: 13, Plt: 137 WBC 5.1 ANC
|